Policy on the Use of Generative AI in Manuscript Preparation
1. Introduction
The International Journal of Medical Justice (IJMJ) recognizes the growing role of generative artificial intelligence (AI) technologies in academic writing. To ensure transparency, integrity, and accountability, IJMJ has established the following guidelines for the use of generative AI in manuscript preparation.
2. Disclosure Requirements
Authors must disclose the use of generative AI tools (e.g., large language models, chatbots, image generation tools) in the preparation of their manuscripts. This disclosure should be included in both the cover letter and a dedicated section within the manuscript. The disclosure must specify the AI tools used, the extent of their use, and the specific content generated by these tools.
3. Authorship and Accountability
Generative AI tools cannot be listed as authors or co-authors. Authors are fully responsible for the content generated by AI tools, including its accuracy, originality, and compliance with ethical standards. Authors must ensure that AI-generated content does not contain plagiarism and is properly cited.
· Fairness Audits: Regularly audit AI tools for fairness and equity, ensuring they do not perpetuate or amplify existing biases
4. Ethical Considerations
Authors must ensure that the use of generative AI does not compromise the ethical standards of the journal. This includes maintaining the confidentiality of sensitive information and avoiding the generation of misleading or false information.
5. Review Process
Reviewers are advised against uploading manuscripts to AI platforms that cannot guarantee confidentiality. Reviewers must disclose any use of AI tools in the evaluation of manuscripts or the drafting of reviewer comments.
6. Compliance and Enforcement
Failure to disclose the use of generative AI tools or to adhere to these guidelines may result in the rejection of the manuscript or retraction of the published article. IJMJ reserves the right to take appropriate action in cases of non-compliance.
Generative AI has the potential to significantly impact medical writing, offering both benefits and risks. Here are some key points to consider:
7. Benefits
8. Risks
9. Data Protection: Ensure that AI tools comply with data protection regulations, safeguarding the privacy and confidentiality of sensitive information .
· Secure Platforms: Use secure platforms for AI processing to prevent unauthorized access and data breaches
10. Conclusion
The IJMJ is committed to fostering innovation while upholding the highest standards of academic integrity. These guidelines aim to balance the benefits of generative AI with the need for transparency and ethical responsibility in scholarly publishing. Balancing benefits and risks are crucial for the responsible use of generative AI in medical writing. Journals can address the ethical concerns related to AI use by implementing comprehensive guidelines and policies. Here are some strategies. By adopting these strategies, journals can address the ethical concerns related to AI use and ensure the integrity and trustworthiness of published research
Correspondence:
Dr Imran Sabri
Editor-in-Chief/Editor
International Journal of Medical Justice
Email: imransabri@gmail.com
Address:
G-1, Ground Floor, City Center, Medical Road,
Aligarh 202002 India
E-Mail:
editor@ijmj.net [Journal]
editor.ijmj@gmail.com,[Editor]
glafims@gmail.com [GLAFIMS ACADEMY]
Website of Journal: www.ijmj.net
Website of GLAFIMS: www.glafims.org [Organization]
Live Membership: www.glafims.com
_____________________________________________________________________________________________________________________________________________________________________________
Head Address: G1, Ground Floor, City Center, Medical Road, Aligarh
202002 India E-Mail: glafims@gmail.com
web: www.glafims.org
Copyright © 2022-32
by Global Academy of Forensic and Investigative Medicine and Science [GLAFIMS
ACADEMY]. All rights
reserved.
Last Updated: November 1, 2022